Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dinovite is an animal health company specializing in nutritional supplements for dogs, cats, and horses. The company's flagship products are designed to address common pet health issues such as excessive shedding, itchy skin, and digestive problems through a blend of probiotics, vitamins, and minerals. Dinovite focuses on the direct-to-consumer market, providing whole-food supplements that aim to restore nutritional balance often missing from commercial pet foods. The company was acquired by PetLab Co. in 2022 to expand its portfolio in the premium pet wellness space. The brand is well-known for its extensive use of radio advertising and its commitment to natural, high-quality ingredients. Dinovite continues to operate as a key brand within the PetLab Group, targeting pet owners seeking holistic health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dinovite.